McKesson stock reports 8 percent revenue growth in Q1
Published on 09/24/2026 at 18:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
McKesson stock was trading at USD 880.01 on the NYSE at 12:43 p.m. ET on September 24, 2026, down 0.06 percent. The healthcare distributor reported Q1 fiscal 2027 revenue of USD 105.38 billion, up 8 percent year over year, according to Zacks.
Revenue reaches USD 105.38 billion
The first-quarter revenue result exceeded the consensus estimate of USD 104.39 billion by 1 percent. Adjusted EPS came in at USD 9.93, 20 percent above the year-ago figure of USD 8.27 and 5.2 percent above the USD 9.44 consensus estimate, according to Zacks.
GAAP EPS was USD 5.15, down 18 percent from USD 6.25 in the year-ago quarter. GLP-1 medication distribution revenue reached USD 15 billion, an increase of 24 percent year over year.
Guidance rises to USD 45.00
McKesson raised fiscal 2027 adjusted EPS guidance to USD 44.20-45.00 from USD 43.80-44.60. The new range implies adjusted EPS growth of 13-15 percent, while revenue growth guidance remains 5-9 percent.
The company also maintained fiscal 2027 free cash flow guidance of USD 4.5-4.9 billion. For investors, the combination of higher earnings guidance and the Q1 revenue beat provides a clearer operating benchmark than the daily share-price move.
Cybersecurity update adds a risk factor
A September 21 update said a cybersecurity incident affected certain third-party applications used by a subset of customers in McKesson's Oncology and Multispecialty business. Becker's Hospital Review reported that the update also covered business contact and order data linked to parts of Medical-Surgical operations.
Stock sits below the yearly high
At USD 880.01, McKesson stock was 11.9 percent below its 52-week high of USD 999.00 and 23.0 percent above its 52-week low of USD 715.31 on September 24, 2026. Market capitalization stood at USD 103,029,810,780 on the same date.
Next earnings date is set
Business Wire reported that McKesson will release second-quarter fiscal 2027 results after market close on November 4, 2026, followed by an investor conference call at 4:30 p.m. ET.
McKesson reference data
- Company: McKesson Corporation
- Ticker: MCK
- Trading venue: NYSE
- Price as of September 24, 2026 at 12:43 p.m. ET: USD 880.01
- Market capitalization: USD 103,029,810,780 as of September 24, 2026
- 52-week range: USD 715.31-999.00 as of September 24, 2026
- Sector / Industry: Healthcare / Medical Distribution
- Next earnings date: November 4, 2026
